Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-01-27 Sale | 2023-01-31 4:19 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 480 | $20.26 | $9,725 | 21,548 (Direct) | View |
2023-01-09 Sale | 2023-01-09 5:11 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 369 | $20.2 | $7,454 | 22,028 (Direct) | View |
2023-01-05 Sale | 2023-01-05 4:56 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 1,421 | $20.2 | $28,704 | 22,397 (Direct) | View |
2022-07-14 Sale | 2022-07-15 4:05 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 627 | $11.85 | $7,430 | 23,818 (Direct) | View |
2022-01-27 Sale | 2022-01-27 4:05 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 1,518 | $26.19 | $39,756 | 22,445 (Direct) | View |
2022-01-10 Sale | 2022-01-12 4:37 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 385 | $30.49 | $11,739 | 23,963 (Direct) | View |
2020-01-07 Sale | 2020-01-09 4:12 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 8,785 | $13.47 | $118,348 | 12,400 (Direct) | View |
2020-01-02 Sale | 2020-01-06 4:16 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 1,215 | $13.96 | $16,963 | 48,785 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-03-02 Disposition | 2023-03-03 09:13 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 23,548 | $20 | 0 (Direct) | View |
2023-03-02 Disposition | 2023-03-03 09:13 am | 2018-08-06 2027-02-06 | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 72,200 | $0 | 0 (Direct) | View |
2023-03-02 Option Award | 2023-03-03 09:13 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 2,000 | $0 | 0 (Direct) | View |
2022-06-27 Option Award | 2022-06-29 4:03 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 2,000 | $0 | 24,445 (Direct) | View |
2022-01-04 Option Award | 2022-01-05 4:22 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 12,000 | $0 | 24,348 (Direct) | View |
2021-01-26 Option Award | 2021-01-27 4:13 pm | N/A 2031-01-26 | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 18,948 | $0 | 23,098 (Direct) | View |
2020-01-07 Option Award | 2020-01-09 4:12 pm | N/A 2030-01-07 | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 12,400 | $0 | 12,400 (Direct) | View |
2020-01-02 Exercise | 2020-01-06 4:16 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 10,000 | $9 | 48,785 (Direct) | View |
2020-01-02 Exercise | 2020-01-06 4:16 pm | 2018-08-06 2027-02-06 | OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer | 10,000 | $0 | 48,785 (Direct) | View |